A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of ReoCure as Monotherapy and in Combination with Keytruda (Pembrolizumab) in Patients with Advanced Malignant Solid Tumours.

  • Voskoboynik, Mark (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date18/09/20 → 31/12/20

Keywords

  • Medical oncology
  • Solid tumours
  • Clinical trial